Proactive Investors - Run By Investors For Investors

Valens GroWorks receives their ACMPR licence from Health Canada

Valens GroWorks (CSE:VGW) Vice President of Operations Chatel Popoff and their Head of Production Quinn Shiskin joined Steve Darling from Proactive Investors on Skype to talk about Valens receiving their access to cannabis for medical purposes regulations licence from Health Canada.

They also shared details about the new emulsion technology called SoRSE and what is means for the company going forward. 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
Meet ICOx Innovations, Zynerba Pharmaceuticals, Pressure BioSciences Inc. and Alchemist Inc at our event, New York , 30 January 2019. Register here »
View full VGW profile View Profile

Valens GroWorks Corporation Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use